Our people

Our world class team

Our top officers have extensive experience with startup and middle-market companies, specifically in the fields of medical devices, technology development, and biomedical science. In addition to our team members below, learn more about our scientific advisory board.

Isaac Eliaz, MD, MS, LAc
Founder / CEO, CSO

Physician & entrepreneur with 30+ years of clinical experience. Gal-3 expert and inventor of Gal-3 inhibitor. Founder of Amitabha Apheresis Clinic, ecoNugenics (acquired in 2023). Multi-patent holder and published author.

Anat Stern, MSc, MBA
COO & Biz Development

Business development, strategy, and operation veteran with 15 years' experience in healthcare and biotechnology. Managed ecoNugenics, a nutraceutical company specializing in Gal-3, for 7 years (resulting in a successful private equity acquisition in 2023).

Rajeev Kumar, PhD
VP of R&D

A proven growth leader in the medical device and healthcare industry. Raj brings over 28 years of research experience in protein biochemistry and molecular biology, including 10 years in R&D for solid organ transplantation IVD.

Milton Goss BSE, MBA

Accomplished, senior accounting and financial management executive with more than 20 years of experience in the medical device, life science, and semiconductor industries.  Prior to finance, worked in product development as a chemical engineer.

Glenn Chertow, MD, MPH
Lead Advisor Clinical Research

Expert in acute kidney failure and chronic kidney disease with more than 30 years of clinical experience. Dr. Chertow has conducted sponsored and NIH-funded trials throughout his career and maintained a research program devoted to improving kidney patient treatment.

Eliaz Therapeutics is seeking seasoned managers who are experts in the medical field, marketing strategy, and regulatory landscape.

Join us in fighting life-threatening diseases.
Learn more about our current investment programs.